Summary
Serial body casting plays an important role in the treatment of early onset scoliosis (EOS), serving as an effective, safer method compared to surgical intervention. The health-related quality of life (HRQoL) of patients with EOS of idiopathic etiology begins within a normal range, but declines while in cast and remains lower after the casting treatment is complete. While patients with non-idiopathic EOS begin with a lower HRQoL, their in-cast deterioration is smaller and recovers after casting is completed.
This is a preview of subscription content, log in via an institution to check access.
Author information
Consortia
Additional information
Author disclosures: Emily Auran: None. Hiroko Matsumoto: None. David P Roye: Medtronic; Stryker; JBJS. Michael G. Vitale: Stryker; Biomet; CSSG; SRS; POSNA; OREF; IPOS; POSNA; SSG.; Wellinks; DePuy Synthes. Peter F. Sturm: Nuvasive; Medtronic; Depuy Synthes; Biomet; Journal of Children’s Orthopaedics. James O. Sanders: Abbott, Abbvie, GE Healthcare. Matthew Oetgen: None. Sumeet Garg: Decision Support in Medicine; Medtronic; US News & World Report Children’s Hospitals Orthopedic Working Group. Children’s Spine Study Group: DePuy Synthes Research Grant. Growing Spine Study Group: Growing Spine Foundation Research Grant Nuvasive Research Grant.
Rights and permissions
About this article
Cite this article
Auran, E., Matsumoto, H., Roye, D.P. et al. Paper #28: Quality of Life and Burden of Care in Patients with EOS Undergoing Casting. Spine Deform 4, 459–460 (2016). https://doi.org/10.1016/j.jspd.2016.09.033
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jspd.2016.09.033